Panavance Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Panavance Therapeutics

Access the complete profile.

Panavance Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	1055 Westlakes Drive Suite 300 Berwyn, PA 19312

Note: Revenues for privately held companies are statistical evaluations.


Panavance Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Panavance Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Panavance Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Panavance Therapeutics Annual Revenue and Growth Rate

Panavance Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Panavance Therapeutics's revenues are gauged from an analysis of company filings.

Panavance Therapeutics's Income Statement (based on Industry Averages)

Panavance Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Panavance Therapeutics is developing and marketing. Panavance Therapeutics doesn't have any recent trademark applications, indicating Panavance Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DISRUPTING CANCER'S ENERGY Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders	01/28/2022

See all trademarks and details in the Full Report.

Market Share of Panavance Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Panavance Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Panavance Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
FUJIREBIO DIAGNOSTICS	Malvern, PA	100
FLAMMA USA	Malvern, PA	6
SHIRE HOLDINGS US AG	Exton, PA	6
AMRING PHARMACEUTICALS	Berwyn, PA	4
VERRICA PHARMACEUTICALS	West Chester, PA	4
ITF PHARMA	Berwyn, PA	2

Other Companies at 1055 Westlakes Drive Suite 300, Berwyn PA

Company	Headquarters	Revenue ($ MM)
SAMARITANS-AT-LAST	Berwyn, PA	100
PREPAY NATION	Berwyn, PA	92
OPTIA GROUP	Berwyn, PA	45
HARNESS SOLUTIONS	Berwyn, PA	0
SELLIQUEST	Berwyn, PA	0

Future Competition: Panavance Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Panavance Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)